News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
487,156 Results
Type
Article (8158)
Company Profile (140)
Press Release (478857)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (167222)
Career Advice (307)
Deals (25813)
Drug Delivery (7)
Drug Development (52913)
Employer Resources (14)
FDA (9775)
Job Trends (8601)
News (238784)
Policy (17968)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (503)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (98)
Alliances (33338)
ALS (107)
Alzheimer's disease (984)
Antibody-drug conjugate (ADC) (279)
Approvals (10416)
Artificial intelligence (328)
ASCO (160)
Autoimmune disease (218)
Automation (29)
Bankruptcy (263)
Belgium (1)
Best Places to Work (6972)
BIO (37)
Biologics (9)
BIOSECURE Act (1)
Biosimilars (114)
BioSpace Insights (18)
Biotechnology (88)
Bladder cancer (139)
Brain cancer (30)
Breast cancer (516)
Cancer (3736)
Cardiovascular disease (225)
Career advice (247)
Career pathing (1)
CAR-T (178)
CDMO (16)
Celiac Disease (1)
Cell therapy (485)
Cervical cancer (35)
Clinical research (48033)
Collaboration (1276)
Commercialization (3)
Compensation (1524)
Complete response letters (34)
COVID-19 (763)
CRISPR (65)
C-suite (799)
Cystic fibrosis (87)
Data (5826)
Denatured (4)
Depression (104)
Dermatology (68)
Diabetes (352)
Diagnostics (4215)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (159)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (73804)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88176)
Executive appointments (711)
FDA (12480)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (24)
Funding (942)
Gene editing (127)
Generative AI (9)
Gene therapy (329)
GLP-1 (296)
Government (948)
Grass and pollen (2)
Guidances (281)
Healthcare (9379)
Hematology (94)
HIV (53)
Huntington's disease (22)
IgA nephropathy (66)
Immunology and inflammation (101)
Immuno-oncology (61)
Indications (159)
Infectious disease (954)
Inflammatory bowel disease (128)
Inflation Reduction Act (4)
Influenza (85)
Intellectual property (259)
Interviews (41)
IPO (12413)
IRA (2)
Job creations (1980)
Job search strategy (237)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5212)
Licensing (17)
Liver cancer (45)
Longevity (19)
Lung cancer (530)
Lymphoma (257)
Machine learning (27)
Management (3)
Manufacturing (575)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8679)
Medtech (8834)
Mergers & acquisitions (14453)
Metabolic disorders (724)
mRNA (61)
Multiple sclerosis (107)
NASH (4)
Neurodegenerative disease (224)
Neuropsychiatric disorders (40)
Neuroscience (1857)
NextGen: Class of 2026 (3166)
Non-profit (847)
Obesity (230)
Opinion (10)
Ovarian cancer (161)
Pain (177)
Pancreatic cancer (206)
Parkinson's disease (204)
Partnered (12)
Patents (492)
Patient recruitment (526)
Patient selection (1)
Peanut (32)
People (41424)
Peptides (1)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15519)
Phase 2 (21444)
Phase 3 (14456)
Pipeline (7639)
Policy (19)
Postmarket research (1573)
Preclinical (6559)
Press Release (35)
Prostate cancer (193)
Psychedelics (7)
Radiopharmaceuticals (194)
Rare diseases (586)
Real estate (3071)
Recruiting (6)
Regenerative medicine (1)
Regulatory (14955)
Reports (23)
Research institute (591)
Resumes & cover letters (45)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (102)
Series A (158)
Series B (123)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (90)
Sponsored (6)
Startups (2030)
Stomach cancer (3)
Supply chain (52)
Vaccines (334)
Venture capital (18)
Weight loss (75)
Women's health (85)
Date
Today (81)
Last 7 days (434)
Last 30 days (1353)
Last 365 days (19128)
2026 (13449)
2025 (19281)
2024 (23031)
2023 (26610)
2022 (34659)
2021 (37256)
2020 (33574)
2019 (23358)
2018 (17575)
2017 (18825)
2016 (18012)
2015 (24341)
2014 (21760)
2013 (18219)
2012 (20293)
2011 (20505)
2010 (20376)
Location
Africa (232)
Alabama (77)
Alaska (2)
Arizona (309)
Arkansas (11)
Asia (18067)
Australia (2125)
California (12304)
Canada (3224)
China (544)
Colorado (493)
Connecticut (425)
Delaware (211)
Europe (25231)
Florida (1844)
Georgia (392)
Hawaii (3)
Idaho (46)
Illinois (725)
India (54)
Indiana (322)
Iowa (17)
Japan (419)
Kansas (104)
Kentucky (31)
Louisiana (27)
Maine (26)
Maryland (1228)
Massachusetts (8083)
Michigan (312)
Minnesota (575)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (120)
New Hampshire (60)
New Jersey (2684)
New Mexico (12)
New York (2884)
North Carolina (1313)
North Dakota (4)
Northern California (6187)
Ohio (291)
Oklahoma (15)
Oregon (16)
Pennsylvania (2291)
Puerto Rico (21)
Rhode Island (30)
South America (413)
South Carolina (77)
South Dakota (1)
Southern California (5118)
Tennessee (123)
Texas (1992)
United States (39894)
Utah (367)
Vermont (1)
Virginia (158)
Washington D.C. (38)
Washington State (955)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
487,156 Results for "apotex fermentation inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Apotex Announces First Quarter 2027 Results
August 12, 2026
·
41 min read
Press Releases
Apotex Completes Previously Announced Strategic Transaction with Cumberland Pharmaceuticals
July 1, 2026
·
3 min read
Press Releases
Apotex announces leadership changes
March 30, 2026
·
2 min read
Press Releases
Apotex to Announce First Quarter Fiscal 2027 Financial Results and Host Conference Call on August 12, 2026
July 9, 2026
·
1 min read
Press Releases
Apotex first to receive Health Canada approval for SEVMIA™, a generic semaglutide for chronic weight management
June 30, 2026
·
5 min read
Press Releases
Apotex launches Apo‑Semaglutide Injection™, a generic equivalent of Ozempic®, in Canada
May 14, 2026
·
2 min read
Press Releases
Apotex Announces Strategic U.S. Sterile Filling Partnership with Halo Pharmaceuticals
April 15, 2026
·
3 min read
Press Releases
Fermeate Raises $2M Seed to Improve Fermentation with Light
April 29, 2026
·
2 min read
Press Releases
Apotex Announces Strategic Transaction with Cumberland Pharmaceuticals to Integrate their U.S. Branded Businesses
April 23, 2026
·
3 min read
Press Releases
Apotex Strengthens Osteoporosis Care in Canada with Health Canada’s Approval of DENOZA™, a Denosumab Biosimilar
April 7, 2026
·
2 min read
1 of 48,716
Next
